PUNE, India, 2021-Feb-22 — /EPR Network/ — The ELISpot and FluoroSpot market is expected to reach USD 287 million by 2023 from USD 135 million in 2018, [read full press release…]
PUNE, India, 2021-Jan-15 — /EPR Network/ — The ELISpot and FluoroSpot market is expected to reach USD 287 million by 2023 from USD 135 million [read full press release…]
PUNE, India, 2020-Dec-18 — /EPR Network/ — The ELISpot and FluoroSpot market is expected to reach USD 287 million by 2023 from USD 135 million [read full press release…]
PUNE, India, 2020-Nov-06 — /EPR Network/ — The ELISpot and FluoroSpot market is expected to reach USD 287 million by 2023 from USD 135 million [read full press release…]
PUNE, India, 2020-Oct-26 — /EPR Network/ — ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), [read full press release…]
PUNE, India, 2020-Sep-29 — /EPR Network/ — The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million [read full press release…]
PUNE, India, 2020-Sep-07 — /EPR Network/ — ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), [read full press release…]
PUNE, India, 2020-Aug-10 — /EPR Network/ — Growth in this ELISpot and FluoroSpot Assay Market is driven by the rising global incidence of chronic diseases, [read full press release…]
PUNE, India, 2020-May-15 — /EPR Network/ — The rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and [read full press release…]
PUNE, India, 2020-Apr-09 — /EPR Network/ — According to the new market research report “ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B [read full press release…]
PUNE, India, 2020-Mar-17 — /EPR Network/ — The report “ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), [read full press release…]
CITY, Country, 2020-Jan-13 — /EPR Network/ — Growth in this market is driven by the rising global incidence of chronic diseases, increasing vaccine development to [read full press release…]
